Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 1
2000 1
2003 1
2004 2
2005 2
2006 4
2007 1
2008 5
2009 1
2010 5
2011 2
2012 1
2013 2
2014 2
2015 2
2016 2
2019 1
2020 3
2021 2
2022 2
2023 4
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.
Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ; PRINTO; PRCSG. Ruperto N, et al. N Engl J Med. 2012 Dec 20;367(25):2396-406. doi: 10.1056/NEJMoa1205099. N Engl J Med. 2012. PMID: 23252526 Free article. Clinical Trial.
[Autoimmune diseases and immunotherapies].
Mogenet A, Duruisseaux M, Grigoriu B, Greillier L. Mogenet A, et al. Rev Mal Respir. 2025 Jul 28:S0761-8425(25)00207-4. doi: 10.1016/j.rmr.2025.07.001. Online ahead of print. Rev Mal Respir. 2025. PMID: 40730767 Review. French.
IRF5 as a potential immunological biomarker in lung adenocarcinoma.
Li S, Zhou F, Lan H, Cao X, Mogenet A, Díaz-Peña R, Zhao M. Li S, et al. Among authors: mogenet a. Transl Cancer Res. 2024 Dec 31;13(12):6936-6946. doi: 10.21037/tcr-2024-2354. Epub 2024 Dec 27. Transl Cancer Res. 2024. PMID: 39816561 Free PMC article.
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).
Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C, Bossuyt X, Boutten A, Bienvenu J, Duquesne A, Richer O, Chaussabel D, Mogenet A, Banchereau J, Treluyer JM, Landais P, Pascual V. Quartier P, et al. Among authors: mogenet a. Ann Rheum Dis. 2011 May;70(5):747-54. doi: 10.1136/ard.2010.134254. Epub 2010 Dec 20. Ann Rheum Dis. 2011. PMID: 21173013 Free PMC article. Clinical Trial.
49 results